Pāriet uz galveno navigāciju Pāriet uz meklēšanu Pāriet uz galveno saturu

Complement genes contribute sex-biased vulnerability in diverse disorders

  • Schizophrenia Working Group of the Psychiatric Genomics Consortium
  • , Psychosis Endophenotypes International Consortium
  • , Wellcome Trust Case–Control Consortium 2
  • Harvard University
  • Broad Institute
  • King's College London
  • University of California at San Francisco
  • University of California at Los Angeles
  • University of Michigan, Ann Arbor
  • University of Alabama at Birmingham
  • VA Medical Center
  • Wake Forest University
  • Howard Hughes Medical Institute
  • Brigham and Women’s Hospital
  • SUNY Downstate Health Sciences University
  • University of Southern California
  • Utrecht University
  • Genentech, Inc
  • Massachusetts General Hospital
  • Trinity College Dublin
  • Cardiff University
  • Eli Lilly
  • Technical University of Denmark
  • Boston Children's Hospital
  • Karolinska Institutet
  • Diakonhjemmet Hospital
  • University of Oslo
  • Aarhus University
  • The Lundbeck Foundation Initiative for Integrative Psychiatric Research
  • Isar-Amper-Klinikum München-Ost
  • Stanford University
  • Department of Veterans Affairs
  • Emory University
  • Virginia Commonwealth University
  • Max Planck Institute of Experimental Medicine
  • University of Pecs
  • University of Iowa
  • University of Groningen
  • Louisiana State University Health Sciences Center
  • Latvian Biomedical Research and Study Centre
  • Icahn School of Medicine at Mount Sinai
  • Schizophrenia Research Institute
  • University of Newcastle
  • Centre Hospitalier du Rouvray and INSERM U1079 Faculty of Medicine
  • University of New South Wales
  • University of Queensland
  • CAS - Institute of Psychology
  • The University of Hong Kong
  • University of North Carolina at Chapel Hill
  • Castle Peak Hospital
  • Singapore Institute of Mental Health
  • Washington University St. Louis
  • Assistance publique – Hôpitaux de Paris
  • Blue Note Biosciences
  • Hospital Universitario Marques de Valdecilla
  • Centro de Investigación Biomédica en Red en Salud Mental (CIBERSAM)
  • Queen Mary University of London
  • University College London
  • Sheba Medical Center at Tel Hashomer
  • Life & Brain GmbH
  • University of Bonn
  • University of Antwerp
  • VA BOSTON HEALTH CARE SYSTEM
  • National and Kapodistrian University of Athens
  • University College Cork
  • University of Galway
  • The University of Chicago
  • NorthShore University HealthSystem
  • London School of Hygiene and Tropical Medicine
  • University Clinic of Psychiatry
  • University of Regensburg
  • Helsinki University Central Hospital
  • Folkhalsan
  • National Institute for Health and Welfare
  • Biomedicum Helsinki
  • F. Hoffmann-La Roche AG
  • Georgetown University
  • Heidelberg University 
  • University of Colorado Anschutz Medical Campus
  • Martin Luther University Halle-Wittenberg
  • Ludwig Maximilian University of Munich
  • Sorbonne Université
  • Mental Health Research Center
  • Johnson & Johnson
  • Academic Medical Centre University of Amsterdam
  • Illumina, Inc.
  • Mental Health Centre Sct. Hans
  • University of Basel
  • Statens Serum Institut
  • Fujita Health University
  • Stavanger University Hospital
  • Vall d'Hebron Research Institute
  • University of Western Australia
  • The University of Western Australia
  • Medical University Sofia
  • University of Colorado Boulder
  • University of Toronto
  • Institute of Molecular Genetics, Russian Academy of Sciences
  • Vilnius University
  • Charles University
  • Duke-NUS Medical School
  • Hadassah University Medical Centre
  • Sichuan University
  • Johns Hopkins University
  • Columbia University
  • Pomeranian Medical University in Szczecin
  • Sørlandet Hospital
  • University of Edinburgh
  • Beth Israel Deaconess Medical Center
  • University of Tartu
  • Royal College of Surgeons in Ireland
  • Maastricht University
  • University of Liverpool
  • Max Planck Institute of Psychiatry
  • Munich Cluster for Systems Neurology (SyNergy)
  • Friedrich Schiller University Jena
  • Umeå University
  • DETECT
  • Queen's University Belfast
  • University of California at Berkeley
  • University of Melbourne
  • University of Helsinki
  • University of Belgrade
  • University of Oxford
  • Pfizer
  • University of Göttingen
  • Friedrich-Alexander University Erlangen-Nürnberg
  • Hunter New England Health
  • National Institutes of Health
  • University of Iceland
  • Tbilisi State Medical University
  • Lieber Institute for Brain Development
  • deCODE Genetics / Amgen
  • Medical University of Vienna
  • Berkshire Healthcare NHS Foundation Trust
  • University of Verona
  • University of Oulu
  • Health Research Board Ireland
  • Agency for Science, Technology and Research, Singapore
  • Jülich Research Centre
  • Hebrew University of Jerusalem
  • Northwell Health System
  • Hempstead
  • Glen Oaks
  • National University of Singapore
  • Erasmus University Rotterdam
  • VU University Medical Center Amsterdam
  • Vrije Universiteit Amsterdam
  • University of Aberdeen
  • University of Copenhagen
  • University of Barcelona
  • Technische Universität Dresden
  • Section for Experimental Psychopathology
  • University of Amsterdam
  • Wellcome Sanger Institute
  • University of Cambridge
  • University of Western Australia
  • Wellcome Trust
  • University of Plymouth
  • St George's University of London
  • Guy's and St Thomas' NHS Foundation Trust
  • University of Dundee
  • Oxford University Hospitals NHS Foundation Trust

Zinātniskās darbības rezultāts: Devums žurnālamZinātniskais raksts (žurnālā)koleģiāli recenzēts

196 Atsauces (Scopus)

Kopsavilkums

Many common illnesses, for reasons that have not been identified, differentially affect men and women. For instance, the autoimmune diseases systemic lupus erythematosus (SLE) and Sjögren’s syndrome affect nine times more women than men1, whereas schizophrenia affects men with greater frequency and severity relative to women2. All three illnesses have their strongest common genetic associations in the major histocompatibility complex (MHC) locus, an association that in SLE and Sjögren’s syndrome has long been thought to arise from alleles of the human leukocyte antigen (HLA) genes at that locus3–6. Here we show that variation of the complement component 4 (C4) genes C4A and C4B, which are also at the MHC locus and have been linked to increased risk for schizophrenia7, generates 7-fold variation in risk for SLE and 16-fold variation in risk for Sjögren’s syndrome among individuals with common C4 genotypes, with C4A protecting more strongly than C4B in both illnesses. The same alleles that increase risk for schizophrenia greatly reduce risk for SLE and Sjögren’s syndrome. In all three illnesses, C4 alleles act more strongly in men than in women: common combinations of C4A and C4B generated 14-fold variation in risk for SLE, 31-fold variation in risk for Sjögren’s syndrome, and 1.7-fold variation in schizophrenia risk among men (versus 6-fold, 15-fold and 1.26-fold variation in risk among women, respectively). At a protein level, both C4 and its effector C3 were present at higher levels in cerebrospinal fluid and plasma8,9 in men than in women among adults aged between 20 and 50 years, corresponding to the ages of differential disease vulnerability. Sex differences in complement protein levels may help to explain the more potent effects of C4 alleles in men, women’s greater risk of SLE and Sjögren’s syndrome and men’s greater vulnerability to schizophrenia. These results implicate the complement system as a source of sexual dimorphism in vulnerability to diverse illnesses.

OriģinālvalodaAngļu
Lapas (no-līdz)577-581
Lapu skaits5
ŽurnālsNature
Sējums582
Izdevuma numurs7813
DOIs
Publikācijas statussPublicēts - 25 jūn. 2020
Ārēji publicēts

Nospiedums

Uzziniet vairāk par pētniecības tēmām “Complement genes contribute sex-biased vulnerability in diverse disorders”. Kopā tie veido unikālu nospiedumu.

Citēt šo